Global Projections and Rising Incidence
Annual new dementia cases worldwide are projected to more than double, rising from 11.4 million in 2023 to 24.7 million by 2050, according to a peer-reviewed study published in The Guardian citing research in JAMA Neurology. The international study, which analyzed data from 22 studies involving more than 38,000 participants across 18 countries, indicated that the surge is primarily driven by expanding life expectancies and growing populations entering older age brackets. Researchers also identified higher risk levels among women and populations living in low- and middle-income countries.
In the United States, the annual number of diagnosed dementia cases is projected to reach 1 million by 2060, up significantly from 514,000 in 2020. Demographic shifts are compounding this trajectory; the Alzheimer’s Association reports that the U.S. Hispanic population nearly doubled between 2000 and 2024, a demographic group that is 1.5 times as likely to develop dementia compared to white populations. Jordan Weiss, an assistant professor at the Optimal Aging Institute at NYU Langone, noted that even with successful risk reduction, the sheer volume of aging adults guarantees a larger population living with cognitive decline.
Healthcare Workforce Shortages and Economic Pressures
The projected increase collides with an already constrained U.S. healthcare infrastructure facing acute staffing deficits in geriatrics, nursing homes, and home care. According to data cited by The Guardian, the active supply of geriatric physicians in the United States dropped from 10,270 in 2000 to 7,413 in 2022, making geriatrics one of the lowest-paid and least-populated medical specialties. Meanwhile, nursing facilities struggle with recruitment and retention; a 2000-to-2035 projection by the Center for American Progress indicates that demand for nursing assistants and home health aides will rise by 48% and 42% respectively.
Direct care providers face strenuous physical and emotional demands paired with low financial compensation. Bureau of Labor Statistics data from May 2025 showed median hourly wages below $19 for nursing assistants in assisted living and home health settings, and $17 for home health aides. Regina Shih, a professor of epidemiology at Emory University, emphasized that direct care retention remains severely depressed because the work is exceptionally difficult and inadequately reimbursed, leaving facilities unable to meet current demand.
Policy Challenges and Clinical Interventions
State and federal policy environments are simultaneously shifting the landscape of long-term care financing. While nearly half of U.S. states offered incentive payments in 2025 to recruit or retain Medicaid home care workers, according to a KFF survey cited by The Guardian, these efforts face headwinds from federal budget measures. The One Big Beautiful Bill Act, enacted in 2025 under the Trump administration, introduced nearly $1 trillion in spending cuts to Medicaid over ten years. Because Medicaid finances more than half of national long-term care expenditures, public health experts warn the cuts will restrict access to home-based care, personal assistance, and respite services.
On the clinical front, medical advancements offer incremental tools for management and early detection. The U.S. Food and Drug Administration (FDA) has approved therapies such as Kisunla and Leqembi, which modestly slow cognitive decline in early-stage Alzheimer’s patients, alongside diagnostic blood tests capable of early detection. However, health economists note that implementing these diagnostics and treatments will introduce substantial new costs to healthcare systems, reinforcing calls from researchers to prioritize preventative measures such as cardiovascular health and physical activity alongside infrastructure investments.